Stuttgart - Delayed Quote EUR

Agios Pharmaceuticals Inc (8AP.SG)

Compare
23.80
+2.20
+(10.19%)
As of 8:11:41 AM GMT+2. Market Open.
Loading Chart for 8AP.SG
  • Previous Close 21.60
  • Open 23.80
  • Bid 22.60 x 100000
  • Ask 22.80 x 100000
  • Day's Range 23.80 - 23.80
  • 52 Week Range 21.60 - 58.00
  • Volume 0
  • Avg. Volume 16
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 30, 2025 - May 5, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 8AP.SG

View More

Performance Overview: 8AP.SG

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

8AP.SG
24.68%
S&P 500 (^GSPC)
11.17%

1-Year Return

8AP.SG
13.77%
S&P 500 (^GSPC)
1.24%

3-Year Return

8AP.SG
13.14%
S&P 500 (^GSPC)
16.40%

5-Year Return

8AP.SG
36.28%
S&P 500 (^GSPC)
87.27%

Compare To: 8AP.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8AP.SG

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    1.37B

  • Enterprise Value

    609.33M

  • Trailing P/E

    2.04

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    37.62

  • Price/Book (mrq)

    0.88

  • Enterprise Value/Revenue

    18.33

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 8AP.SG

View More

Company Insights: 8AP.SG

Research Reports: 8AP.SG

View More